Tuesday, August 14, 2018 11:24:21 PM
These omitted forms have prevented every current GERS shareholder and every potential GERS shareholder from using any due dilligence to make an investment decision.
A lawsuit could even be filed, saying that financial losses (or missed opportunities to make profits) were caused by Kevin's gross negligence and the fact that the information in the Q3 2016 10-Q report is now false information because of Kevin's transfer of one or more Greenshift patents to Attis since the third quarter of 2016.
The hypothetical lawsuit could also ask for compensation for the expected higher value of GERS stock, based on the forward earnings from the license revenue. This revenue, and the bottom-line earnings that this hypothetical shareholder expected that Greenshift would receive from the licensees, is, instead, going to the bottom line of Attis industries.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM